Top 10 search results for "does alone have experience with flare positive elevator cancer matters ca 15 3 and ca 27 29" in Treatments. To see all results and access other features, sign up for free.

Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-Zzxf) for Breast Cancer

Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with…

Beizray (Docetaxel) for Breast Cancer

Overview

Beizray is approved by the U.S. Food and Drug Administration (FDA) for the treatment of breast cancer. It is indicated as a single agent for locally advanced or metastatic breast cancer after failure of previous…

Talzenna (Talazoparib) for Breast Cancer

Talzenna (talazoparib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with deleterious or suspected deleterious germline BRCA-mutated…

Tukysa (Tucatinib) for Breast Cancer

Tukysa (tucatinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with human epidermal growth factor receptor-2 (HER2)-positive breast…

Nerlynx (Neratinib) for Breast Cancer

Nerlynx (neratinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Veppanu (Vepdegestrant) for Breast Cancer

Veppanu (vepdegestrant) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Piqray (Alpelisib) for Breast Cancer

Piqray (alpelisib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) in combination with fulvestrant to treat adults with HR-positive…

Tykerb (Lapatinib) for Breast Cancer

Tykerb (lapatinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Itovebi (Inavolisib) for Breast Cancer

Itovebi (inavolisib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat some adults with certain types of breast cancer.

Trazimera (Trastuzumab-Qyyp) for Breast Cancer

Trazimera (trastuzumab-qyyp) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.